18F-FDG
PekingUFH-MM-BC1
Phase 1 small_molecule active
Quick answer
18F-FDG for Multiple Myeloma and Malignant Plasma Cell Neoplasms is a Phase 1 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Multiple Myeloma and Malignant Plasma Cell Neoplasms
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active